These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 11781363)

  • 1. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein.
    Crotta S; Stilla A; Wack A; D'Andrea A; Nuti S; D'Oro U; Mosca M; Filliponi F; Brunetto RM; Bonino F; Abrignani S; Valiante NM
    J Exp Med; 2002 Jan; 195(1):35-41. PubMed ID: 11781363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions.
    Tseng CT; Klimpel GR
    J Exp Med; 2002 Jan; 195(1):43-9. PubMed ID: 11781364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.
    Crotta S; Brazzoli M; Piccioli D; Valiante NM; Wack A
    J Hepatol; 2010 Feb; 52(2):183-90. PubMed ID: 20015567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoskeleton rearrangement induced by tetraspanin engagement modulates the activation of T and NK cells.
    Crotta S; Ronconi V; Ulivieri C; Baldari CT; Valiante NM; Abrignani S; Wack A
    Eur J Immunol; 2006 Apr; 36(4):919-29. PubMed ID: 16552713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
    Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
    PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell costimulation by the hepatitis C virus envelope protein E2 binding to CD81 is mediated by Lck.
    Soldaini E; Wack A; D'Oro U; Nuti S; Ulivieri C; Baldari CT; Abrignani S
    Eur J Immunol; 2003 Feb; 33(2):455-64. PubMed ID: 12645944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein.
    Heo TH; Chang JH; Lee JW; Foung SK; Dubuisson J; Kang CY
    J Immunol; 2004 Jul; 173(1):446-55. PubMed ID: 15210804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.
    Yoon JC; Shiina M; Ahlenstiel G; Rehermann B
    Hepatology; 2009 Jan; 49(1):12-21. PubMed ID: 19085909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
    Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
    Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
    Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
    J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The small extracellular loop of CD81 is necessary for optimal surface expression of the large loop, a putative HCV receptor.
    Masciopinto F; Campagnoli S; Abrignani S; Uematsu Y; Pileri P
    Virus Res; 2001 Nov; 80(1-2):1-10. PubMed ID: 11597743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection.
    Meola A; Sbardellati A; Bruni Ercole B; Cerretani M; Pezzanera M; Ceccacci A; Vitelli A; Levy S; Nicosia A; Traboni C; McKeating J; Scarselli E
    J Virol; 2000 Jul; 74(13):5933-8. PubMed ID: 10846074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells.
    Wack A; Soldaini E; Tseng C; Nuti S; Klimpel G; Abrignani S
    Eur J Immunol; 2001 Jan; 31(1):166-75. PubMed ID: 11169450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological changes in different patient populations with chronic hepatitis C virus infection.
    Szereday L; Meggyes M; Halasz M; Szekeres-Bartho J; Par A; Par G
    World J Gastroenterol; 2016 May; 22(20):4848-59. PubMed ID: 27239111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.
    Wellnitz S; Klumpp B; Barth H; Ito S; Depla E; Dubuisson J; Blum HE; Baumert TF
    J Virol; 2002 Feb; 76(3):1181-93. PubMed ID: 11773394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of hepatitis C virus to CD81.
    Pileri P; Uematsu Y; Campagnoli S; Galli G; Falugi F; Petracca R; Weiner AJ; Houghton M; Rosa D; Grandi G; Abrignani S
    Science; 1998 Oct; 282(5390):938-41. PubMed ID: 9794763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.